表紙
市場調查報告書
商品編碼
1081232

全球無內胎胰島素泵市場:按最終用途劃分的市場規模、行業分析、按地區劃分的前景、按用途劃分的未來潛力、競爭性市場份額、未來預測2022-2030

Tubeless Insulin Pump Market Size By End-use, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2022 - 2030

出版日期: | 出版商: Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

由於全球糖尿病患者人數的增加,預計到 2030 年,全球無內胎胰島素泵市場將顯著增長。

此外,與糖尿病相關的醫療費用上漲預計將進一步推動未來市場增長。

按最終用戶計算,2021 年家庭醫療保健行業的收入份額將超過 76%。

本報告分析了全球無內胎胰島素泵市場,分析了行業基本結構和向心力、技術/監管環境、主要市場促進/制約因素、按終端應用/地區劃分的市場趨勢展望、主要我們是調查公司概況、業務績效、戰略等。

目錄

第一章分析方法

第2章執行摘要

第三章對無內胎胰島素泵行業的思考

  • 行業分類
  • 產業情況(單位:100萬美元,2017-2030)
  • 行業影響因素
    • 生長促進劑
    • 行業潛在風險和挑戰
  • 增長潛力分析
  • 新型冠狀病毒感染(COVID-19)的影響分析
  • 監管狀態
  • 波特五力分析
  • 競爭形勢 (2021)
    • 公司矩陣分析 (2021)
  • PESTEL 分析

第 4 章無內胎胰島素泵市場:按最終用途分類

  • 主要細分市場的趨勢
  • 家庭醫療
    • 市場規模:按地區劃分(單位:100 萬美元,2017-2030)
  • 醫院/診所
  • 其他

第 5 章無內胎胰島素泵市場:按地區劃分

  • 按地區劃分的主要趨勢
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 意大利
    • 法國
    • 西班牙
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 澳大利亞
  • 其他領域

第 6 章公司簡介

  • 競爭儀表板 (2021)
  • Insulet Corporation
  • Roche
  • Medtrum Technologies
  • Terumo Corporation
  • Zealand Pharma
  • MicroTech Medical Inc.
目錄
Product Code: 2032

The tubeless insulin pump market is estimated to grow massively by 2030 owing to growing occurrences of diabetes around the world. In addition, escalating healthcare expenses associated with diabetes are projected to further propel market growth through the forecast timespan.

The tubeless insulin pump is an effective way to control diabetes through a Bluetooth-connected insulin management system that eliminates the need for daily insulin injections. Recent technological advances have improved pump systems by connecting tubeless insulin pumps to smartphone-type devices, which has fostered product outlook.

After the coronavirus outbreak, the burgeoning cost of insulin pumps due to worldwide supply chain disruptions impeded tubeless insulin pump market growth in the initial stages of the pandemic. However, collaborative efforts between private and public organizations have helped the market regain its pre-COVID momentum. For instance, in May 2021, Roche Diabetes Care, an innovative diabetes technologies services company, launched the mySugr Pump Control system embedded in the mySugr app to improve insulin pump therapy through smartphones.

To cite another instance, in January 2022, Insulet, a leading specialist in tubeless insulin pumps, received U.S. FDA approval for OmniPod 5, its tubeless automated insulin delivery (AID) system that can control daily insulin dosage according to the blood sugar level, in individuals over the age of six diagnosed with type 1 diabetes. The patch-like device can be easily controlled through a smartphone via the Dexcom G6 CGM (continuous glucose monitoring) system. Earlier, in July 2021, the OmniPod 5 AID system had reported successful results in a pivotal trial to reduce HbA 1c levels in children and adults with type 1 diabetes.

In another instance, in November 2021, Terumo Corporation, a medical device corporation, joined hands with a European company to enable MEDISAFE WITH, an insulin patch pump, that can be controlled by smartphone-type devices. The partnership was intended to help Terumo to enhance the operability of MEDISAFE WITH as well as normalize insulin pump therapy in the daily lives of patients.

The tubeless insulin pump market has been bifurcated based on end-use and region. In terms of end-use, the market has been further divided into hospitals & clinics, homecare, and others. The homecare segment dominated the market with more than 76% revenue share in 2021 as a result of technological advancements, growing product adoption, and soaring user preference.

In the regional landscape, apart from North America, Asia Pacific, and Europe, the RoW tubeless insulin pump market is projected to witness notable growth to be valued at around $50 million by 2030 due to the high prevalence of diabetes as well as mounting product uptake across various countries in the region.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definition
  • 1.2 Base estimates & working
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Tubeless insulin pump industry 360 degree synopsis, 2017 - 2030
    • 2.1.1 Business trends
    • 2.1.2 End-use trends
    • 2.1.3 Regional trends

Chapter 3 Tubeless Insulin Pump Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2030 (USD Million)
  • 3.3 Industry impact factors
    • 3.3.1 Growth drivers
      • 3.3.1.1 Rising prevalence of diabetes
      • 3.3.1.2 Technological advancements in tubeless insulin pump
      • 3.3.1.3 Increasing diabetes care expenditure
      • 3.3.1.4 Injuries caused by conventional & invasive insulin pumps
      • 3.3.1.5 Adoption of facilitative initiatives
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 High long-term costs associated with tubeless insulin pump
      • 3.3.2.2 Stringent government regulations
  • 3.4 Growth potential analysis
    • 3.4.1 By end-use
  • 3.5 COVID-19 impact analysis
  • 3.6 Regulatory landscape
    • 3.6.1 U.S.
    • 3.6.2 Europe
  • 3.7 Porter's analysis
  • 3.8 Competitive landscape, 2021
    • 3.8.1 Company matrix analysis, 2021
  • 3.9 PESTEL analysis

Chapter 4 Tubeless Insulin Pump Market, By End-use

  • 4.1 Key segment trends
  • 4.2 Home care
    • 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.3 Hospitals & clinics
    • 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.4 Others
    • 4.4.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 5 Tubeless Insulin Pump Market, By Region

  • 5.1 Key regional trends
  • 5.2 North America
    • 5.2.1 Market size, by country, 2017 - 2030 (USD Million)
    • 5.2.2 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.2.3 U.S.
      • 5.2.3.1 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.2.4 Canada
      • 5.2.4.1 Market size, by end-use, 2017 - 2030 (USD Million)
  • 5.3 Europe
    • 5.3.1 Market size, by country, 2017 - 2030 (USD Million)
    • 5.3.2 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.3.3 Germany
      • 5.3.3.1 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.3.4 UK
      • 5.3.4.1 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.3.5 Italy
      • 5.3.5.1 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.3.6 France
      • 5.3.6.1 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.3.7 Spain
      • 5.3.7.1 Market size, by end-use, 2017 - 2030 (USD Million)
  • 5.4 Asia Pacific
    • 5.4.1 Market size, by country, 2017 - 2030 (USD Million)
    • 5.4.2 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.4.3 China
      • 5.4.3.1 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.4.4 Japan
      • 5.4.4.1 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.4.5 South Korea
      • 5.4.5.1 Market size, by end-use, 2017 - 2030 (USD Million)
    • 5.4.6 Australia
      • 5.4.6.1 Market size, by end-use, 2017 - 2030 (USD Million)
  • 5.5 RoW
    • 5.5.1 Market size, by end-use, 2017 - 2030 (USD Million)

Chapter 6 Company Profiles

  • 6.1 Competitive dashboard, 2021
  • 6.2 Insulet Corporation
    • 6.2.1 Business overview
    • 6.2.2 Financial data
    • 6.2.3 Product landscape
    • 6.2.4 Strategic outlook
    • 6.2.5 SWOT analysis
  • 6.3 Roche
    • 6.3.1 Business overview
    • 6.3.2 Financial data
    • 6.3.3 Product landscape
    • 6.3.4 Strategic outlook
    • 6.3.5 SWOT analysis
  • 6.4 Medtrum Technologies
    • 6.4.1 Business overview
    • 6.4.2 Financial data
    • 6.4.3 Product landscape
    • 6.4.4 Strategic outlook
    • 6.4.5 SWOT analysis
  • 6.5 Terumo Corporation
    • 6.5.1 Business overview
    • 6.5.2 Financial data
    • 6.5.3 Product landscape
    • 6.5.4 Strategic outlook
    • 6.5.5 SWOT analysis
  • 6.6 Zealand Pharma
    • 6.6.1 Business overview
    • 6.6.2 Financial data
    • 6.6.3 Product landscape
    • 6.6.4 Strategic outlook
    • 6.6.5 SWOT analysis
  • 6.7 MicroTech Medical Inc.
    • 6.7.1 Business overview
    • 6.7.2 Financial data
    • 6.7.3 Product landscape
    • 6.7.4 Strategic outlook
    • 6.7.5 SWOT analysis

Data Tables

  • TABLE 1. Tubeless insulin pump industry 360 degree synopsis, 2017 - 2030
  • TABLE 2. Global tubeless insulin pump market, 2017 - 2021 (USD Million)
  • TABLE 3. Global tubeless insulin pump market, 2022 - 2030 (USD Million)
  • TABLE 4. Global tubeless insulin pump market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 5. Global tubeless insulin pump market, by end-use, 2022 - 2030 (USD Million)
  • TABLE 6. Global tubeless insulin pump market, by region, 2017 - 2021 (USD Million)
  • TABLE 7. Global tubeless insulin pump market, by region, 2022 - 2030 (USD Million)
  • TABLE 8. Industry impact forces
  • TABLE 9. Home care market size, by region, 2017 - 2021 (USD Million)
  • TABLE 10. Home care market size, by region, 2022 - 2030 (USD Million)
  • TABLE 11. Hospitals & clinics market size, by region, 2017 - 2021 (USD Million)
  • TABLE 12. Hospitals & clinics market size, by region, 2022 - 2030 (USD Million)
  • TABLE 13. Others market size, by region, 2017 - 2021 (USD Million)
  • TABLE 14. Others market size, by region, 2022 - 2030 (USD Million)
  • TABLE 15. North America tubeless insulin pump market size, by country, 2017 - 2021 (USD Million)
  • TABLE 16. North America tubeless insulin pump market size, by country, 2022 - 2030 (USD Million)
  • TABLE 17. North America tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 18. North America tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 19. U.S. tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 20. U.S. tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 21. Canada tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 22. Canada tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 23. Europe tubeless insulin pump market size, by country, 2017 - 2021 (USD Million)
  • TABLE 24. Europe tubeless insulin pump market size, by country, 2022 - 2030 (USD Million)
  • TABLE 25. Europe tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 26. Europe tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 27. Germany tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 28. Germany tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 29. UK tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 30. UK tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 31. France tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 32. France tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 33. Spain tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 34. Spain tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 35. Italy tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 36. Italy tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 37. Asia Pacific tubeless insulin pump market size, by country, 2017 - 2021 (USD Million)
  • TABLE 38. Asia Pacific tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 39. Asia Pacific tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 40. China tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 41. China tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 42. Japan tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 43. Japan tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 44. South Korea tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 45. South Korea tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 46. Australia tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 47. Australia tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)
  • TABLE 48. RoW tubeless insulin pump market size, by country, 2017 - 2021 (USD Million)
  • TABLE 49. RoW tubeless insulin pump market size, by country, 2022 - 2030 (USD Million)
  • TABLE 50. RoW tubeless insulin pump market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 51. RoW tubeless insulin pump market size, by end-use, 2022 - 2030 (USD Million)

Charts & Figures

  • FIG. 1 Top-down approach (supply side analysis)
  • FIG. 2 Data Validation
  • FIG. 3 Global tubeless insulin pump 360 degree synopsis, 2017 - 2030
  • FIG. 4 Industry segmentation
  • FIG. 5 Global tubeless insulin pump market size, 2017 - 2030 (USD Million)
  • FIG. 6 Growth potential analysis, by end-use
  • FIG. 7 Porter's analysis
  • FIG. 8 Competitive matrix analysis, 2021
  • FIG. 9 PESTEL analysis
  • FIG. 10 Key segment trends, by end-use
  • FIG. 11 Key regional trends
  • FIG. 12 Competitive dashboard, 2021